Circle Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $654K | Buy |
3,007
+2,096
| +230% | +$465K | 0.01% | 174 |
|
|
2025
Q4 | $208K | Buy |
+911
| New | +$208K | ﹤0.01% | 237 |
|
|
2024
Q3 | – | Sell |
-1,418
| Closed | -$243K | – | 215 |
|
|
2024
Q2 | $243K | Sell |
1,418
-1,144
| -45% | -$190K | 0.01% | 206 |
|
|
2024
Q1 | $466K | Buy |
2,562
+109
| +4% | +$18.8K | 0.01% | 149 |
|
|
2023
Q4 | $380K | Sell |
2,453
-121
| -5% | -$17.6K | 0.01% | 152 |
|
|
2023
Q3 | $384K | Buy |
2,574
+121
| +5% | +$17.8K | 0.01% | 154 |
|
|
2023
Q2 | $330K | Sell |
2,453
-2
| -0.1% | -$293 | 0.04% | 129 |
|
|
2023
Q1 | $391K | Hold |
2,455
| – | – | 0.06% | 119 |
|
|
2022
Q4 | $397K | Buy |
2,455
+167
| +7% | +$25.6K | 0.06% | 117 |
|
|
2022
Q3 | $307K | Sell |
2,288
-202
| -8% | -$29K | 0.05% | 133 |
|
|
2022
Q2 | $381K | Sell |
2,490
-7
| -0.3% | -$1.07K | 0.06% | 121 |
|
|
2022
Q1 | $405K | Sell |
2,497
-24
| -1% | -$3.49K | 0.05% | 137 |
|
|
2021
Q4 | $341K | Sell |
2,521
-2,243
| -47% | -$265K | 0.04% | 151 |
|
|
2021
Q3 | $514K | Sell |
4,764
-1,564
| -25% | -$179K | 0.07% | 118 |
|
|
2021
Q2 | $713K | Sell |
6,328
-182
| -3% | -$20.5K | 0.1% | 102 |
|
|
2021
Q1 | $704K | Buy |
6,510
+1,150
| +21% | +$123K | 0.11% | 86 |
|
|
2020
Q4 | $574K | Buy |
5,360
+15
| +0.3% | +$1.44K | 0.08% | 135 |
|
|
2020
Q3 | $468K | Buy |
5,345
+28
| +0.5% | +$2.64K | 0.08% | 121 |
|
|
2020
Q2 | $522K | Buy |
5,317
+413
| +8% | +$36.4K | 0.09% | 104 |
|
|
2020
Q1 | $374K | Buy |
4,904
+139
| +3% | +$11.8K | 0.07% | 129 |
|
|
2019
Q4 | $422K | Sell |
4,765
-132
| -3% | -$11K | 0.07% | 119 |
|
|
2019
Q3 | $371K | Buy |
4,897
+45
| +0.9% | +$3.08K | 0.08% | 116 |
|
|
2019
Q2 | $353K | Buy |
4,852
+1,717
| +55% | +$135K | 0.08% | 113 |
|
|
2019
Q1 | $253K | Hold |
3,135
| – | – | 0.06% | 136 |
|
|
2018
Q4 | $289K | Buy |
3,135
+24
| +0.8% | +$2.11K | 0.11% | 62 |
|
|
2018
Q3 | $294K | Buy |
3,111
+22
| +0.7% | +$2.09K | 0.09% | 78 |
|
|
2018
Q2 | $286K | Sell |
3,089
-302
| -9% | -$29.5K | 0.1% | 82 |
|
|
2018
Q1 | $321K | Buy |
3,391
+119
| +4% | +$13.1K | 0.12% | 70 |
|
|
2017
Q4 | $316K | Buy |
3,272
+114
| +4% | +$10.7K | 0.12% | 73 |
|
|
2017
Q3 | $281K | Buy |
3,158
+139
| +5% | +$10.6K | 0.12% | 70 |
|
|
2017
Q2 | $219K | Buy |
+3,019
| New | +$203K | 0.1% | 75 |
|
Other funds holding ABBV
VCM
VPM
Circle Wealth Management's ABBV Position: Q1 2026 in Review
Circle Wealth Management increased its AbbVie (ABBV) stake by 230% in Q1 2026, buying an estimated $465K and bringing the position to 3,007 shares worth $654K. The position accounts for 0.01% of the portfolio, ranked #174.
Circle Wealth Management first reported a position in ABBV in Q2 2017 and has held it in 31 quarters since. The position peaked at $713K in Q2 2021. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Circle Wealth Management held 3,007 shares of AbbVie worth $654K as of Q1 2026.
- Circle Wealth Management bought 2,096 AbbVie shares in Q1 2026, an estimated $465K.
- AbbVie made up 0.01% of Circle Wealth Management's portfolio in Q1 2026, its #174 holding.
- Circle Wealth Management first reported a position in AbbVie in Q2 2017 and has held it in 31 quarters since.
- Circle Wealth Management's AbbVie position peaked at $713K in Q2 2021.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Circle Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.